JENNIFER SORIA: Open Payments
NPI 1477783272 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 7 companies in 2025. Trend: 2023 $150 · 2024 $125 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| PFIZER INC. | 2 | $34 |
| Boston Scientific Corporation | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: CAPLYTA, PREVNAR 20, Intracept, Epclusa, MAVYRET, Ozempic, NEXLETOL.
Industry payments across NE — which companies pay providers there.
